Sage Journals: Discover world-class research

Free access

Research article

First published 2016-4

Improvement in Renal Function and Bone Mineral Density after a Switch from Tenofovir/Emtricitabine plus Ritonavir-Boosted Protease Inhibitor to Raltegravir plus Nevirapine: A Pilot Study

Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli [...]

Antiviral Therapy

Retricted access

Research article

First published 2021-01

Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine

Leonardo Calza, Marco Borderi, Vincenzo Colangeli [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2012-02

Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical Practice

Gabriel Vallecillo, Pere Domingo, Josep Mallolas [...]

AIDS Research and Human Retroviruses

Retricted access

Research article

First published 2009-09

Efficacy and Safety of Atazanavir-Ritonavir Plus Abacavir-Lamivudine or Tenofovir-Emtricitabine in Patients with Hyperlipidaemia Switched from a Stable Protease Inhibitor-Based Regimen Including One Thymidine Analogue

Leonardo Calza, Roberto Manfredi, Vincenzo Colangeli [...]

AIDS Patient Care and STDs

Open access

Research article

First published 2018

Combination Therapy with Tenofovir Disoproxil Fumarate/Emtricitabine/Elvitegravir/Cobicistat Plus Darunavir Once Daily in Antiretroviral-Naive and Treatment-Experienced Patients: A Retrospective Review

Mark J. Naccarato, Deborah M. Yoong, Ignatius W. Fong [...]

Journal of the International Association of Providers of AIDS Care (JIAPAC)

Retricted access

Research article

First published 2019-1

Clinical Outcomes Associated With Once-Daily Ritonavir-Boosted Darunavir Plus Tenofovir/Emtricitabine in HIV-Infected Patients Harboring at Minimum a M184V/I Resistance Mutation

Eric G. Sahloff, Joan M. Duggan

Annals of Pharmacotherapy

Free access

Research article

First published 2013-10

96-Week Results of Abacavir/Lamivudine versus Tenofovir/Emtricitabine,plus Efavirenz,in Antiretroviral-Naive,HIV-1-Infected Adults: Assert Study

Graeme J Moyle, Hans-Jürgen Stellbrink, Juliet Compston [...]

Antiviral Therapy

Retricted access

Research article

First published 2011-4

Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects

D E Smith, D J Chan, H Maruszak [...]

International Journal of STD & AIDS

Retricted access

Research article

First published 2013-02

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir

Esteban Martínez, Polyana M. d'Albuquerque, Ignacio Pérez [...]

AIDS Research and Human Retroviruses

Open access

Review article

First published 2017

Preexposure Prophylaxis—a New Addition to the Armamentarium Against Human Immunodeficiency Virus

Maabo Kludze

Clinical Medicine Insights: Therapeutics

Search results